These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 33278181

  • 1. Qualitative Perceptions of Dapivirine VR Adherence and Drug Level Feedback Following an Open-Label Extension Trial.
    Naidoo K, Mansoor LE, Katz AWK, Garcia M, Kemigisha D, Morar NS, Zimba CC, Chitukuta M, Reddy K, Soto-Torres L, Naidoo S, Montgomery ET.
    J Acquir Immune Defic Syndr; 2021 Apr 01; 86(4):e90-e96. PubMed ID: 33278181
    [Abstract] [Full Text] [Related]

  • 2. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
    Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, Gati Mirembe B, Mhlanga F, Hunidzarira P, Mansoor LE, Siva S, Govender V, Makanani B, Naidoo L, Singh N, Nair G, Chinula L, Parikh UM, Mellors JW, Balán IC, Ngure K, van der Straten A, Scheckter R, Garcia M, Peda M, Patterson K, Livant E, Bunge K, Singh D, Jacobson C, Jiao Y, Hendrix CW, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Torjesen K, Nel A, Rosenberg Z, Soto-Torres LE, Hillier SL, Brown ER, MTN-025/HOPE Study Team.
    Lancet HIV; 2021 Feb 01; 8(2):e87-e95. PubMed ID: 33539762
    [Abstract] [Full Text] [Related]

  • 3. Women's motivations for participating in the dapivirine vaginal ring open label extension study.
    Naidoo K, Montgomery ET, Katz AWK, Garcia M, Naidoo S, Mansoor LE.
    AIDS Care; 2024 Mar 01; 36(3):326-342. PubMed ID: 37734338
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study.
    Naidoo K, T ME, Katz AW, Morgan G, Krishnaveni R, Lydia ST, Sarita N, Leila ME.
    AIDS Behav; 2023 Jan 01; 27(1):75-81. PubMed ID: 35672549
    [Abstract] [Full Text] [Related]

  • 5. Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring.
    Katz AWK, Balán IC, Reddy K, Etima J, Weber K, Tauya T, Atujuna M, Scheckter R, Ngure K, Soto-Torres L, Mgodi N, Palanee-Phillips T, Baeten JM, van der Straten A.
    AIDS Behav; 2022 Nov 01; 26(11):3607-3619. PubMed ID: 35536519
    [Abstract] [Full Text] [Related]

  • 6. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study.
    Nel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A, Steytler J, van der Ryst E, Craig C, Louw C, Gwetu T, Mabude Z, Kotze P, Moraba R, Tempelman H, Gill K, Kusemererwa S, Bekker LG, Devlin B, Rosenberg Z, DREAM Study Team.
    Lancet HIV; 2021 Feb 01; 8(2):e77-e86. PubMed ID: 33539761
    [Abstract] [Full Text] [Related]

  • 7. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
    Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2020 Mar 01; 24(3):866-880. PubMed ID: 31111297
    [Abstract] [Full Text] [Related]

  • 8. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial.
    Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, Kabwigu S, Matovu Kiweewa F, Govender V, Gaffoor Z, Singh N, Siva S, Naidoo K, Montgomery ET, for the MTN-020/ASPIRE Team.
    AIDS Behav; 2020 May 01; 24(5):1432-1442. PubMed ID: 31667678
    [Abstract] [Full Text] [Related]

  • 9. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe.
    Montgomery ET, Katz AWK, Duby Z, Mansoor LE, Morar NS, Naidoo K, Tsidya M, Chitukuta M, Guma V, Tenza S, Leslie J, Garcia M, Naidoo S.
    AIDS Behav; 2021 Jun 01; 25(6):1890-1900. PubMed ID: 33389318
    [Abstract] [Full Text] [Related]

  • 10. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial.
    Brown ER, Hendrix CW, van der Straten A, Kiweewa FM, Mgodi NM, Palanee-Philips T, Marzinke MA, Bekker LG, Soto-Torres L, Hillier SL, Baeten JM, MTN-020/ASPIRE Study Team.
    J Int AIDS Soc; 2020 Nov 01; 23(11):e25634. PubMed ID: 33206462
    [Abstract] [Full Text] [Related]

  • 11. Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex.
    Laborde ND, Pleasants E, Reddy K, Atujuna M, Nakyanzi T, Chitukuta M, Naidoo S, Palanee-Phillips T, Baeten JM, Montgomery ET, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2018 Feb 01; 22(2):437-446. PubMed ID: 29151197
    [Abstract] [Full Text] [Related]

  • 12. Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe.
    Stoner MCD, Mathebula F, Sedze N, Seyama L, Mohuba R, Fabiano Z, Etima J, Young A, Scheckter R, van der Straten A, Piper J, Noguchi L, Montgomery ET, Balán IC.
    AIDS Behav; 2024 Jul 01; 28(7):2264-2275. PubMed ID: 38526641
    [Abstract] [Full Text] [Related]

  • 13. Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial.
    Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, Mathebula F, Zimba C, Mansoor LE, Singh D, Manengamambo E, Naidoo S, Soto-Torres L, Montgomery ET, MTN-020/ASPIRE, MTN 025/HOPE, MTN-032 Study teams.
    AIDS Behav; 2022 May 01; 26(5):1597-1606. PubMed ID: 34727272
    [Abstract] [Full Text] [Related]

  • 14. Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa.
    Leslie J, Kiweewa F, Palanee-Phillips T, Bunge K, Mhlanga F, Kamira B, Baeten J, Katz A, Hillier S, Montgomery E, MTN-020/ASPIRE Study Team.
    BMC Womens Health; 2021 Apr 23; 21(1):175. PubMed ID: 33892693
    [Abstract] [Full Text] [Related]

  • 15. Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa.
    Gichane MW, Katz AWK, Ngure K, Scheckter R, Woeber K, Reddy K, Tauya T, Zimba C, Etima J, Mangxilana N, Palanee-Phillips T, van der Straten A, MTN-025/HOPE Study Team.
    AIDS Behav; 2021 Dec 23; 25(12):3847-3857. PubMed ID: 34009480
    [Abstract] [Full Text] [Related]

  • 16. Qualitative Study on the Acceptability of and Adherence to a Vaginal Ring for HIV Prophylaxis Among Adolescent Girls.
    Baker Z, Javanbakht M, Moore J, Brosnan H, Squires K, Bunge K, Zimet G, Mensch B, Soto-Torres L, Kapogiannis B, Levy L, Hoesley C, Reirden D, Gaur A, Mayer K, Futterman D, Gorbach P.
    J Acquir Immune Defic Syndr; 2021 Jul 01; 87(3):944-950. PubMed ID: 33675614
    [Abstract] [Full Text] [Related]

  • 17. Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027).
    Milford C, Ramlal H, Mofokeng R, Rambally Greener L, Nel A, Smit J, Malherbe M.
    BMC Public Health; 2024 May 31; 24(1):1458. PubMed ID: 38822304
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study.
    Montgomery ET, Roberts ST, Reddy K, Tolley E, Hartmann M, Wilson E, Mathebula F, Wagner LD, Zissette S, Lanham M, Wilcher R, Baeten JM, Palanee-Phillips T.
    AIDS Behav; 2022 Mar 31; 26(3):752-763. PubMed ID: 34546473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.